Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from dual agonists such as tirzepatide and single agonists such as semaglutide
These companies currently offer five GLP-1 drugs approved for type 2 diabetes, with four also approved for various cardiovascular conditions
At age 20, plasma concentrations average around 200 ng/mL
However, no standardized combination protocols exist, and the interaction between exogenous MGF and IGF-1 LR3 has not been systematically studied in vivo
doi:10.1093/ajcn/33.5.989
While it has not been conclusively established whether this dysfunction is a cause or consequence of the pathological processes, growing evidence suggests that reduced proteasomal activity may contribute to the accumulation of toxic protein aggregates and the progression of neurodegeneration